From: Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
Age at time of diagnosis: median (range) | 59.5 year (range: 26 to 89) | |
---|---|---|
No. | % | |
FIGO stage | ||
IB2 | 4 | 10.3 |
IIA | 2 | 5.1 |
IIB | 20 | 51.3 |
IIIB | 9 | 23.1 |
IVA | 4 | 10.3 |
Size of primary tumors | ||
Tumors < 4 cm | 6 | 15.4 |
Tumors > 4 cm | 33 | 84.6 |
Lymph nodes status | ||
N0 | 15 | 38.5 |
N1 | 24 | 61.5 |
Paraaortic Positive LN | 5 | 12.8 |
Median number of positive LN per patient | 2.5 (range: 1 to 5) | |
Tumor histology | ||
No | % | |
Adenocarcinoma | 9 | 23.1 |
Squamous Cell Carcinoma | 30 | 76.9 |
Tumor grade | ||
Grade 1 | 1 | 2.6 |
Grade 2 | 25 | 64.1 |
Grade 3 | 13 | 33.3 |